Page 112 - MemoriaBBN-Eng

RESEARCH GROUPS

á

á
á

í
í
íííí
í

Á

ú
íí

Á

NanoBioCel: Micro and Nano Technologies,
PROGRAMME:
Nanomedicine
Biomaterials and Cells Research Group

Group Members
Lead Researcher

STAFF MEMBERS
Pedraz Muñoz, José Luis

Acarregui Garalde, Argia
Ciriza Astrain, Jess
Contact:
Losada Narvaez, ngela
rea de Farmacia y Ciencias de los Alimentos.
Facultad de Farmacia de Vitoria. ASSOCIATED MEMBERS

Po Universidad, 7. Esquisabel Alegra, Amaia
E.mail: [email protected]
Hernndez Martn, Rosa Mara

Website: http://www.ehu.es/en/web/nanobiocel/home
Igartua Olaechea, Manuela
Orive Arroyo, Gorka

Portero Landa, Aitziber
Zrate Sesma, Jon
Main lines of research

CONTRIBUTORS
• MICROENCAPSULATION OF ALIVE CELLS: Design and optimization of po-
Acarregui Garalde, Argia lymeric systems for immobilization of cells with therapeutic activity. This

Agirre Diez, Mireia system provides protection to cells against the host’s immune response due
Egusquiaguirre Martn, Susana P.
to its technological design, and at the same time, it turns into a controlled
Gainza Luzea, Garazi release pharmaceutical system.
Garate Letona , Ane
• MICRO AND NANO-PARTICLES AS VACCINE ADMINISTRATION SYSTEMS OF 13
Gartziandia L. de Goikoetxea, Oihane 20
PEPTIDES AND PROTEINS: Promising results obtained by our research group T
Herrn Martnez, Enara R
Moreno Sastre, Mara support the use of these drug (antigen) carrier systems to develop vaccines, PO
as demonstrated by the results after their administration by different routes E
Pastor Navarro, Marta L R
Saenz del Burgo Martnez, Laura in laboratory animals (mice and monkeys), inducing a sustained and strong A
NU
Salvador Martnez, Aiala immune response.
N
Santos Vizcano, Edorta
A
• NON VIRAL VECTORS FOR GENE THERAPY PURPOSES: Design and optimi- /
zation of non-viral vectors based on lipidic and polymeric nanoparticles to BN
B
transfect eukaryotic cells with therapeutic genes.
R-
BE
• DEVELOPMENT OF MODIFIED RELEASE FORMULATIONS: Development and CI

112
optimization of drug delivery systems based on new polymers to obtain a
sustained release profile of drugs.